Isotocyanozene
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Isotocyanozene (5-cyano-isotodesnitazene) is a benzimidazole opioid analogue of isotonitazene which has been sold as a designer drug.[1] It was first characterised by the drug checking service CanTEST, in September 2025 as an expected 'opioid' sample, and then later as an expected 'benzodiazepine' sample.[2][3] Its μ-opioid in vitro activity is close to that of fentanyl.[4] Following identification in human biological samples, isotocyanozene has been described to have opioid effects.[5]
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C24H30N4O |
| Molar mass | 390.531 g·mol−1 |
| 3D model (JSmol) | |
| |
| |